Splice-variant- and stage-specific RNA editing of the drosophila GABA receptor modulates agonist potency

Benedict Sattelle, Andrew K. Jones, Steven D. Buckingham, Magdalini Papadaki, Maiko Yokota, Benedict M. Sattelle, Kazuhiko Matsuda, David B. Sattelle

    Research output: Contribution to journalArticlepeer-review

    Abstract

    The molecular diversity of many gene products functioning in the nervous system is enhanced by alternative splicing and adenosine-to-inosine editing of pre-mRNA. Using RDL, a Drosophila melanogaster GABA-gated ion channel, we examined the functional impact of RNA editing at several sites along with alternative splicing of more than one exon. We show that alternative splicing and RNA editing have a combined influence on the potency of the neurotransmitter GABA, and the editing isoforms detected in vivo span the entire functional range of potencies seen for all possible edit variants expressed in Xenopus laevis oocytes. The extent of RNA editing is developmentally regulated and can also be linked to the choice of alternative exons. These results provide insights into how the rich diversity of signaling necessary for complex brain function can be achieved by relatively few genes. Copyright © 2009 Society for Neuroscience.
    Original languageEnglish
    Pages (from-to)4287-4292
    Number of pages5
    JournalJournal of Neuroscience
    Volume29
    Issue number13
    DOIs
    Publication statusPublished - 1 Apr 2009

    Fingerprint

    Dive into the research topics of 'Splice-variant- and stage-specific RNA editing of the drosophila GABA receptor modulates agonist potency'. Together they form a unique fingerprint.

    Cite this